EPM2A and neoplasm: Our findings suggest that EPM2 AIP1 immunohistochemistry offers greater specificity, as it allows the evaluation of histological slides, thereby minimizing the risk of false negative methylation tests caused by normal tissue contamination or a low tumor cell percentage.